EUVIMEDEUVIMED entdecken
Crossref

Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury

Yoko Igarashi-Hisayoshi iD, Eikichi Ihara, Xiaopeng Bai, Yoshimasa Tanaka, Haruei Ogino, Takatoshi Chinen, Yasushi Taguchi, Yoshihiro Ogawa

Journal of Molecular Medicine · 2024

DOI: 10.1007/s00109-024-02474-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2024. Verfasst von Yoko Igarashi-Hisayoshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, Mochida Pharmaceutical Co., Ltd, 722 Uenohara, Jimba, Gotemba, 412-8524, Japan. yoko.igarashi.729@mochida.co.jp. Hauptthemen laut MEDLINE: Indomethacin, Intestine, Small, Receptor, Muscarinic M3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: KAKENHI, Mochida Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

EP4 prostanoid receptor (EP4R) contributes to the intestinal epithelial Cl- secretion, and inhibition of prostaglandin E (PGE) production by non-steroidal anti-inflammatory drugs (NSAIDs) plays a central role in NSAID-induced enteropathy. Although M3 muscarinic acetylcholine receptor (M3R) also contributes to the intestinal epithelial Cl- secretion, it remains unclear whether M3R is involved in NSAID-induced enteropathy due to a lack of selective agents. The present study explored how M3R is involved in the regulation of the intestinal epithelial Cl- secretion and its pathophysiological role in NSAID-induced enteropathy. Using the novel highly-selective M3 positive allosteric modulator PAM-369 that we recently developed, we evaluated the role of M3R in the intestinal epithelial secretion ex vivo by measuring the short circuit current (Isc) of intestinal epithelium with a Ussing chamber system and examined whether or not M3R protects against small intestinal injury in indomethacin-treated mice. Both the PGE1 derivative misoprostol and carbachol similarly increased the Isc in a concentration-dependent manner. The Isc increases were abolished either by receptor antagonists (an EP4R antagonist and a M3R antagonist, respectively) or by removal of extracellular Cl-. PAM-369 enhanced the carbachol-induced Isc by potentiating M3R, which could contribute to enhanced intestinal epithelial secretion. Treatment with PAM-369 ameliorated small intestinal injury in indomethacin-treated mice. Importantly, the M3R expression was significantly up-regulated, and PAM-369 potentiation of M3R was augmented in indomethacin-treated mice compared to untreated mice. These findings show that M3R plays a role in maintaining the intestinal epithelial secretion, which could contribute to protection against indomethacin-induced small intestinal injury. M3R is a promising target for treating or preventing NSAID-induced enteropathy. KEY MESSAGES: PAM-369, the M3 positive allosteric modulator, was used to potentiate M3R. PAM-369 enhanced carbachol-induced Isc in mouse ileum. PAM-369 ameliorated small intestinal injury in indomethacin-treated mice. M3R is a promising target for treating or preventing NSAID-induced enteropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinIntestine, SmallReceptor, Muscarinic M3AnimalsMaleMiceAnti-Inflammatory Agents, Non-SteroidalCarbacholIntestinal MucosaMice, Inbred C57BLMisoprostol

Stichwörter der Autor:innen

Intestinal epithelial Cl− secretionM3 muscarinic acetylcholine receptorNSAID-induced enteropathyPositive allosteric modulator

Substanzen

Anti-Inflammatory Agents, Non-SteroidalCarbacholIndomethacinMisoprostolReceptor, Muscarinic M3Chrm3 protein, mouse

Autor:innen und Institutionen

  • Research Center, Mochida Pharmaceutical Co., Ltd, 722 Uenohara, Jimba, Gotemba, 412-8524, Japan. yoko.igarashi.729@mochida.co.jp.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. yoko.igarashi.729@mochida.co.jp.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
  • Department of Gastroenterology and Metabolism, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
  • Research Center, Mochida Pharmaceutical Co., Ltd, 722 Uenohara, Jimba, Gotemba, 412-8524, Japan.

ORCID-Profile: Yoko Igarashi-Hisayoshi

Förderung

  • KAKENHI
  • Mochida Pharmaceutical Company

Zitieren

APA

Igarashi-Hisayoshi, Y., Ihara, E., Bai, X., Tanaka, Y., Ogino, H., Chinen, T., Taguchi, Y., & Ogawa, Y. (2024). Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-024-02474-0

Vancouver

Igarashi-Hisayoshi Y, Ihara E, Bai X, Tanaka Y, Ogino H, Chinen T, et al. Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury. Journal of Molecular Medicine. 2024. doi:10.1007/s00109-024-02474-0

BibTeX
@article{IgarashiHisayoshi2024,
  author = {Igarashi-Hisayoshi, Yoko and Ihara, Eikichi and Bai, Xiaopeng and Tanaka, Yoshimasa and Ogino, Haruei and Chinen, Takatoshi and Taguchi, Yasushi and Ogawa, Yoshihiro},
  title = {Protective role of M3 muscarinic acetylcholine receptor in indomethacin-induced small intestinal injury},
  journal = {Journal of Molecular Medicine},
  year = {2024},
  doi = {10.1007/s00109-024-02474-0}
}
Kostenlos starten →